Catheter Precision closes USD 3.47 million private placement of Series C-3 convertible preferred stock
VTAK•Private placement closed
Catheter Precision closed a private placement on July 15, 2026, issuing 3,470 shares of Series C-3 Convertible Preferred Stock for USD 3.47 million.
Key terms of the preferred stock
The preferred shares carry a USD 1,000 stated value. Holders can convert the shares into common stock at USD 0.63 per share, subject to a USD 0.35 floor.
Conversion is capped by a 4.99% beneficial ownership limit, with an option to raise that limit to 9.99% on 61 days’ notice.
Use of proceeds and placement agent
Net proceeds are earmarked for working capital, loan repayment, and general corporate purposes. Dawson James Securities served as placement agent.
Offering exemptions and resale registration
The issuance relied on Section 4(a)(2) and Rule 506(b) exemptions. The related was declared effective on .
